| CTRI Number |
CTRI/2022/01/039123 [Registered on: 04/01/2022] Trial Registered Prospectively |
| Last Modified On: |
13/12/2022 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Medical Device |
| Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
|
Public Title of Study
|
Trial of tDCS as Early Augmentation in Adults with Depression |
|
Scientific Title of Study
|
Randomised Controlled Single Blind Trial of Transcranial Direct Current Stimulation
(tDCS) as Early Augmentation in Major Depressive Disorder
|
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Babli Kumari |
| Designation |
Junior Resident |
| Affiliation |
King Georges Medical University, Lucknow |
| Address |
Department of Psychiatry
King George’s Medical
University, Lucknow
Lucknow UTTAR PRADESH 226003 India |
| Phone |
8603342638 |
| Fax |
|
| Email |
bablikumari.bk@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Sujit Kumar Kar |
| Designation |
Additional Professor |
| Affiliation |
King Georges Medical University, Lucknow |
| Address |
Department of Psychiatry
King George’s Medical
University, Lucknow
Lucknow UTTAR PRADESH 226003 India |
| Phone |
9956273747 |
| Fax |
|
| Email |
drsujita@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Babli Kumari |
| Designation |
Junior Resident |
| Affiliation |
King Georges Medical University, Lucknow |
| Address |
Department of Psychiatry
King George’s Medical
University, Lucknow
Lucknow UTTAR PRADESH 226003 India |
| Phone |
08603342638 |
| Fax |
|
| Email |
bablikumari.bk@gmail.com |
|
|
Source of Monetary or Material Support
|
| King Georges Medical University, Shah Mina Road, Chowk, Lucknow, Uttar Pradesh 226003 |
|
|
Primary Sponsor
|
| Name |
King Georges Medical University Lucknow |
| Address |
Department of Psychiatry,
King Georges Medical University,
Shah Mina Road, Chowk Lucknow- 226003 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Babli Kumari |
King Georges Medical University, Lucknow |
Department of Psychiatry,
King Georges Medical University, Lucknow
Lucknow UTTAR PRADESH |
8603342638
bablikumari.bk@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee, King Georges Medical University, UP |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: F321||Major depressive disorder, singleepisode, moderate, (2) ICD-10 Condition: F322||Major depressive disorder, singleepisode, severe without psychotic features, (3) ICD-10 Condition: F331||Major depressive disorder, recurrent, moderate, (4) ICD-10 Condition: F332||Major depressive disorder, recurrent severe without psychotic features, |
|
Intervention / Comparator Agent
Modification(s)
|
| Type |
Name |
Details |
| Intervention |
Active Transcranial Direct Current Stimulation (tDCS) |
A total of 10 sessions (on a daily basis) of tDCS will be delivered over a period of two weeks following a uniform treatment protocol as described below. TOI (Target of Interest): Right DLPFC: Cathode placement, Left DLPFC: Anode placement
Strength of electric current : 2 mA Duration of therapy: 20 minutes/session Sessions: 10 over a period of 2 weeks RAMP time: 20 seconds along with medications |
| Comparator Agent |
Sham Transcranial Direct Current Stimulation (tDCS) |
A total of 10 sessions (on a daily basis) of tDCS will be delivered over a period of two weeks following a uniform treatment protocol as described below. TOI (Target of Interest): Right DLPFC: Cathode placement, Left DLPFC: Anode placement
Strength of electric current : 0.1 mA Duration of therapy: 20 minutes/session Sessions: 10 over a period of 2 weeks RAMP time: 20 seconds along with medications |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
1. Age 18-60 years
2. Patients diagnosed with Major Depressive Disorder according to DSM-5
3. Willing to give Informed consent to participate in the study.
4. Drug Naive (at least drug free for the past 1 month) |
|
| ExclusionCriteria |
| Details |
1. Patients with Treatment Resistant Depression.
2. Patients having Psychotic Depression.
Suicidal Patients
3. HAM-D (Hamilton Depression Rating Scale) less than 13
4. Medical co-morbidities that need immediate attention.
5. Any contraindications to tDCS.
6. Patients with any other co-morbid psychiatric disorder except Tobacco use disorders. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Participant Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To study efficacy of transcranial direct current stimulation in Major Depressive Disorder |
Assessment at 0, 2 and 4 weeks |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To study safety of transcranial direct current stimulation in Major Depressive Disorder |
Assessment at each session |
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
10/01/2022 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Closed to Recruitment of Participants |
|
Publication Details
|
NIL |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
Modification(s)
|
Major Depressive Disorder (MDD) has the highest lifetime prevalence among various psychiatric disorders. It leads to poor quality of life and impaired role functioning. Many pharmacological (antidepressants) and non-pharmacological modalities (cognitive behavioural therapy) are used for the management. Despite adequate treatment, 20-30% of patients could not achieve remission. Various augmentation strategies are then used. Neuromodulation strategies repetitive transcranial magnetic stimulation (rTMS), and transcranial direct current stimulation (tDCS) have been implicated in refractory cases. tDCS has been found to be effective in managing depressive symptoms in various RCTs but its role as an early augmentation strategy has not been studied much. It is a relatively novel non-pharmacological intervention that has significant advantages over other Brain Stimulation Techniques in terms of portability, cost-effectiveness and safety. This study aims to determine the efficacy & safety of Transcranial Direct Current Stimulation (tDCS) as early augmentation in Drug Naive Patients with Major Depressive Disorder.†Procedure: Patients will be recruited from the Adult Psychiatry Outpatient Services and Emergency Services, King George Medical University, Lucknow, Uttar Pradesh, India. Patients fulfilling the selection criteria will be enrolled and written informed consent will be taken. On the day of enrollment, Hamilton- Depression Rating Scale (HAM-D) and Beck’s Depression Inventory (BDI) will be a applied to assess severity of depressive symptoms and Hamilton- Anxiety Rating Scale (HAM-A) for anxiety symptoms. tDCS side effects check-list will be applied to monitor the side-effects. Patients will be randomly allocated to two groups (Active and Sham tDCS) by random table method. Both groups of patients will be blind to the therapy procedure and prescribed uniform antidepressant medications. tDCS will be delivered as per the protocol. A total of 10 sessions will be given within 2 weeks and assessments will be done at baseline, week 2 and week 4 of the enrollment. Result: After data collection, statistical analysis will be done using a computerised statistical program, Statistical Package for Social Sciences (SPSS). Mean change in rating scales will be compared after each assessment as well as between the two groups. |